Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
Ying ZhangLi-Rong LiangShu ZhangYong LuYang-Yu ChenHuan-Zhong ShiYing-Xiang LinPublished in: International journal of chronic obstructive pulmonary disease (2020)
Patients with increased eosinophils (using eosinophil 150 cells/μL as a cutoff value), especially predominantly increased eosinophil levels based on multiple measurements, had a lower risk of all-cause mortality. Blood eosinophilia can be used as a biomarker in hospitalized COPD exacerbations for predicting the risk of all-cause mortality.